The hypothalamic–pituitary–adrenal axis: Cortisol, DHEA and mental and behavioural function

Depression and Physical Illness

Volumn , Issue , 2006, Pages 280-298

  Goodyer, Ian M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84927089993     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1017/CBO9780511544293.014     Document Type: Chapter

References (76)

1. E. P. Guazzo, P. J. Kirkpatrick, I. M. Goodyer, S. Shiers, J. Herbert, Cortisol, dehydroepiandrosterone (DHEA), and DHEA sulfate in the cerebrospinal fluid of man: relation to blood levels and the effects of age. J. Clin. Endocrinol. Metab.81(1996), 3951–60.
2. E. E. Baulieu, Neurosteroids: a novel function of the brain. Psychoneuroendocrinology23(1998), 963–87.
3. D. Liu, J. S. Dillon, Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2, 3). J. Biol. Chem.277(2002), 21 379–88.
4. K. K. Karishma, J. Herbert, Dehydroepiandrosterone (DHEA) stimulates neurogenesis in the hippocampus of the rat, promotes survival of newly formed neurons and prevents corticosterone-induced suppression. Eur. J. Neurosci.16(2002), 445–53.
5. V. G. Kimonides, M. G. Spillantini, M. V. Sofroniew, J. W. Fawcett, J. Herbert, Dehydroepiandrosterone antagonizes the neurotoxic effects of corticosterone and translocation of stress-activated protein kinase 3 in hippocampal primary cultures. Neuroscience89(1999), 429–36.
6. V. G. Kimonides, N. H. Khatibi, C. N. Svendsen, M. V. Sofroniew, J. Herbert, Dehydroepiandrosterone (DHEA) and DHEA-sulfate (DHEAS) protect hippocampal neurons against excitatory amino acid-induced neurotoxicity. Proc. Natl. Acad. Sci. U. S. A.95(1998), 1852–7.
7. D. T. Chalmers, S. P. Kwak, A. Mansour, H. Akil, S. J. Watson, Corticosteroids regulate brain hippocampal 5-HT1A receptor mRNA expression. J. Neurosci.13(1993), 914–23.
8. S. Wissink, O. Meijers, D. Pearce, B. van der Berg, P. van der Saag, Regulation of the rat serotonin-1A receptor gene by corticosteroids. J. Biol. Chem.275(2000), 1321–6.
9. R. Rosmond, Y. C. Chagnon, M. Chagnon, et al., A polymorphism of the 5′-flanking region of the glucocorticoid receptor gene locus is associated with basal cortisol secretion in men. Metabolism49(2000), 1197–9.
10. R. Rosmond, M. Chagnon, C. Bouchard, P. Bjorntorp, A polymorphism in the regulatory region of the corticotropin-releasing hormone gene in relation to cortisol secretion, obesity, and gene–gene interaction. Metabolism50(2001), 1059–62.
11. C. B. Nemeroff, New directions in the development of antidepressants: the interface of neurobiology and psychiatry. Hum. Psychopharmacol.17: Suppl 1 (2002), 13–16.
12. J. W. Smoller, J. F. Rosenbaum, J. Biederman, et al., Association of a genetic marker at the corticotropin-releasing hormone locuswith behavioral inhibition. Biol. Psychiatry54(2003), 1376–81.
13. J. W. Smoller, J. F. Rosenbaum, J. Biederman, et al., Genetic association analysis of behavioral inhibition using candidate loci from mouse models. Am. J. Med. Genet.105(2001), 226–35.
14. B. G. Challis, J. Luan, J. Keogh, et al., Genetic variation in the corticotrophin-releasing factor receptors: identification of single-nucleotide polymorphisms and association studies with obesity in UK Caucasians. Int. J. Obes. Relat. Metab. Disord.28(2004), 442–6.
15. M. R. Gunnar, B. Donzella, Social regulationof the cortisol levels in earlyhumandevelopment. Psychoneuroendocrinology27(2002), 199–220.
16. M. Bartels, E. J. de Geus, C. Kirschbaum, F. Sluyter, D. I. Boomsma, Heritability of daytime cortisol levels in children. Behav. Genet. 33(2003), 421–33.
17. P. Linkowski, A. Van Onderbergen, M. Kerkhofs, et al., Twin study of the 24-h cortisol profile: evidence for genetic control of the human circadian clock. Am. J. Physiol.264(1993), E173–81.
18. A. W. Meikle, J. D. Stringham, M. G. Woodward, D. T. Bishop, Heritability of variation of plasma cortisol levels. Metabolism37(1988), 514–17.
19. I. M. Goodyer, J. Herbert, P. M. E. Altham, et al., Adrenal secretion during major depression in 8 to 16 year olds: I. Altered diurnal rhythms in salivary cortisol and dehydroepiandrosterone (DHEA) at presentation. Psychol. Med.19(1996), 245–56.
20. C. Kirschbaum, D. Hellhammer, Salivary cortisol in psychoendocrine research: recent developments and applications. Psychoneuroendocrinology19(1994), 313–33.
21. I. M. Goodyer, J. Herbert, A. Tamplin, P. M. Altham, First-episode major depression in adolescents: affective, cognitive and endocrine characteristics of risk status and predictors of onset. Br. J. Psychiatry176(2000), 142–9.
22. M. R. Gunnar, Qualityof early care and buffering of neuroendocrine stress reactions: potential effects on the developing human brain. Prev. Med.27(1998), 208–11.
23. J. C. Pruessner, O. T. Wolf, D. H. Hellhammer, et al., Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci. 61(1997), 2539–49.
24. J. C. Pruessner, D. H. Hellhammer, C. Kirschbaum, Burnout, perceived stress, and cortisol responses to awakening. Psychosom. Med.61(1999), 197–204.
25. P. M. Plotsky, M. J. Owens, C. B. Nemeroff, Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis. Psychiatr. Clin. North Am.21(1998), 293–307.
26. M. Deuschle, U. Schweiger, U. Gotthardt, et al., The combined dexamethasone/corticotropinreleasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test. Biol. Psychiatry43(1998), 762–6.
27. S. Watson, P. Gallagher, D. Del-Estal, et al., Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol. Med.32(2002), 1021–8.
28. S. B. Park, D. J. Williamson, P. J. Cowen, 5-HT neuroendocrine function in major depression: prolactin and cortisol responses to d-fenfluramine. Psychol. Med.26(1996), 1191–6.
29. I. M. Goodyer, J. Herbert, A. Tamplin, P. M. Altham, Recent life events, cortisol, dehydroepiandrosterone and the onset of major depression in high-risk adolescents. Br. J. Psychiatry177(2000), 499–504.
30. T. O. Harris, S. Borsanyi, S. Messari, et al., Morning cortisol as a risk factor for subsequent major depressive disorder in adult women. Br. J. Psychiatry177(2000), 505–10.
31. P. L. Strickland, J. F. Deakin, C. Percival, et al., Bio-social origins of depression in the community: interactions between a. dversity. social, cortisol and serotonin neurotransmission. Br. J. Psychiatry180(2002), 168–73.
32. I. M. Goodyer, J. Herbert, A. Tamplin, Psychoendocrine antecedents of persistent first-episode major depression in adolescents: a community-based longitudinal enquiry. Psychol.Med.33(2003), 601–10.
33. J. W. Newcomer, G. Selke, A. K. Melson, et al., Decreased memory performance in healthy humans induced by stress-level cortisol treatment. Arch. Gen. Psychiatry56(1999), 527–33.
34. S. J. Lupien, C. W. Wilkinson, S. Briere, et al., The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology27(2002), 401–16.
35. S. J. Lupien, M. Lepage, Stress, memory, and the hippocampus: can’t live with it, can’t live without it. Behav. Brain Res.127(2001), 137–58.
36. S. J. Lupien, S. King, M. J. Meaney, B. S. McEwen, Can poverty get under your skin? Basal cortisol levels and cognitive function in children from low and high socioeconomic status. Devel. Psychopathol.13(2001), 653–76.
37. S. J. Lupien, C. W. Wilkinson, S. Briere, et al., Acute modulation of aged human memory by pharmacological manipulation of glucocorticoids. J. Clin. Endocrinol. Metab.87(2002), 3798–807.
38. S. J. Lupien, S. King, M. J. Meaney, B. S. McEwen, Child’s stress hormone levels correlate with mother’s socioeconomic status and depressive state. Biol. Psychiatry48(2000), 976–80.
39. W. C. Drevets, Neuroimaging abnormalities in the amygdala in mood disorders. Ann. N. Y. Acad. Sci.985(2003), 420–44.
40. D. A. Seminowicz, H. S. Mayberg, A. R. McIntosh, et al., Limbic-frontal circuitry in major depression: a path modeling metanalysis. Neuroimage22(2004), 409–18.
41. M. Liotti, H. S. Mayberg, S. K. Brannan, et al., Differential limbic–cortical correlates of sadness and anxiety in healthy subjects: implication for affective disorders. Biol. Psychiatry48(2000), 30–42.
42. J. H. Meyer, S. Kapur, B. Eisfeld, et al., The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study. Am. J. Psychiatry158(2001), 78–85.
43. S. Wust, E. F. Van Rossum, I. S. Federenko, et al., Common polymorphisms in the glucocorticoid receptor gene are associated with adrenocortical responses to psychosocial stress. J. Clin. Endocrinol. Metab.89(2004), 565–73.
44. A. Stevens, D. W. Ray, E. Zeggini, et al., Glucocorticoid sensitivity is determined by a specific glucocorticoid receptor haplotype. J. Clin. Endocrinol. Metab.89(2004), 892–7.
45. E. F. Van Rossum, P. G. Voorhoeve, S. J. te Velde, et al., The ER22/23EK polymorphism in the glucocorticoid receptor gene is associated with a beneficial body composition and muscle strength in young adults. J. Clin. Endocrinol. Metab.89(2004), 4004–4009.
46. E. F. van Rossum, J. W. Koper, A. W. van den Beld, et al., Identification of the BclI polymorphism in the glucocorticoid receptor gene: association with sensitivity to glucocorticoids in vivo and body mass index. Clin. Endocrinol. (Oxf.)59(2003), 585–92.
47. P. D. Kroboth, F. S. Salek, A. L. Pittenger, T. J. Fabian, R. F. Frye, DHEA and DHEA-S: a review. J. Clin. Pharmacol.39(1999), 327–48.
48. C. R. Parker, Dehydroepiandrosterone and dehydroepiandrosterone sulfate production in the human adrenal during development and aging. Steroids64(1999), 640–47.
49. F. Labrie, A. Belanger, L. Cusan, J. L. Gomez, B. Candas, Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J. Clin. Endocrinol. Metab.82(1997), 2396–402.
50. P. D. Kroboth, J. A. Amico, R. A. Stone, et al., Influence of DHEA administration on 24-hour cortisol concentrations. J. Clin. Psychopharmacol.23(2003), 96–9.
51. I. M. Goodyer, R. J. Park, J. Herbert, Psychosocial and endocrine features of chronic firstepisode major depression in 8–16 year olds. Biol. Psychiatry50(2001), 351–7.
52. A. Beishuizen, L. G. Thijs, I. Vermes, Decreased levels of dehydroepiandrosterone sulphate in severe critical illness: a sign of exhausted adrenal reserve? Crit. Care6(2002), 434–8.
53. C. Marx, S. Petros, S. R. Bornstein, et al., Adrenocortical hormones in survivors and nonsurvivors of severe sepsis: diverse time course of dehydroepiandrosterone, dehydroepiandrosterone-sulfate, and cortisol. Crit. Care Med.31(2003), 1382–8.
54. F. A. Huppert, J. K. Van Niekerk, Dehydroepiandrosterone (DHEA) supplementation for cognitive function. Cochrane Database Syst. Rev.2(2001), CD000304.
55. P. J. Hunt, E. M. Gurnell, F. A. Huppert, et al., Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison’s disease in a randomized, double blind trial. J. Clin. Endocrinol. Metab.85(2000), 4650–56.
56. J. K. van Niekerk, F. A. Huppert, J. Herbert, Salivary cortisol and DHEA: association with measures of cognition and well-being in normal older men, and effects of three months of DHEA supplementation. Psychoneuroendocrinology26(2001), 591–612.
57. O. M. Wolkowitz, V. I. Reus, A. Keebler, et al., Double-blind treatment of major depression with dehydroepiandrosterone. Am. J. Psychiatry156(1999), 646–9.
58. R. D. Strous, R. Maayan, R. Lapidus, et al., Dehydroepiandrosterone augmentation in the management of negative, depressive, and anxiety symptoms in schizophrenia. Arch. Gen. Psychiatry60(2003), 133–41.
59. I. C. Weaver, N. Cervoni, F. A. Champagne, et al., Epigenetic programming by maternal behavior. Nat. Neurosci.7(2004), 847–54.
60. S. L. Halligan, J. Herbert, I. M. Goodyer, L. Murray, Exposure to postnatal depression predicts elevated cortisol in adolescent offspring. Biol. Psychiatry55(2004), 376–81.
61. M. Champoux, A. Bennett, C. Shannon, et al., Serotonin transporter gene polymorphism, differential early rearing, and behavior in rhesus monkey neonates. Mol. Psychiatry7(2002), 1058–63.
62. A. Caspi, K. Sugden, T. E. Moffitt, et al., Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science301(2003), 386–9.
63. M. R. Gunnar, S. J. Morison, K. Chisholm, M. Schuder, Salivary cortisol levels in children adopted from Romanian orphanages. Dev. Psychopathol.13(2001), 611–28.
64. R. Yehuda, S. L. Halligan, J. A. Golier, R. Grossman, L. M. Bierer, Effects of trauma exposure on the cortisol response to dexamethasone administration in PTSD and major depressive disorder. Psychoneuroendocrinology29(2004), 389–404.
65. R. Loeber, S. M. Green, B. B. Lahey, P. J. Frick, K. McBurnett, Findings on disruptive behavior disorders fromthe first decade of the Developmental Trends Study. Clin. Child. Fam. Psychol. Rev.3(2000), 37–60.
66. K. Pajer, W. Gardner, R. T. Rubin, J. Perel, S. Neal, Decreased cortisol levels in adolescent girls with conduct disorder. Arch. Gen. Psychiatry58(2001), 297–302.
67. A. A. Stone, J. E. Schwartz, J. Smyth, et al., Individual differences in the diurnal cycle of salivary free cortisol: a replication of flattened cycles for some individuals. Psychoneuroendocrinology26(2001), 295–306.
68. S. H. van Goozen, W. Matthys, P. T. Cohen-Kettenis, et al., Salivary cortisol and cardiovascular activity during stress in oppositional-defiant disorder boys and normal controls. Biol. Psychiatry43(1998), 531–9.
69. S. H. van Goozen, W. Matthys, P. T. Cohen-Kettenis, J. K. Buitelaar, H. van Engeland, Hypothalamic-pituitary-adrenal axis and autonomic nervous system activity in disruptive children and matched controls. J. Am. Acad. Child. Adolesc. Psychiatry39(2000), 1438–45.
70. A. Raine, P. H. Venables, S. A. Mednick, Low resting heart rate at age 3 years predisposes to aggression at age 11 years: evidence from the Mauritius Child Health Project. J. Am. Acad. Child. Adolesc. Psychiatry36(1997), 1457–64.
71. A. Raine, C. Reynolds, P. H. Venables, S. A. Mednick, D. P. Farrington, Fearlessness, stimulation-seeking, and large body size at age 3 years as early predispositions to childhood aggression at age 11 years. Arch. Gen. Psychiatry55(1998), 745–51.
72. R. J. Blair, E. Colledge, L. Murray, D. G. Mitchell, A selective impairment in the processing of sad and fearful expressions in children with psychopathic tendencies. J. Abnorm. Child Psychol.29(2001), 491–8.
73. A. Raine, T. Lencz, S. Bihrle, L. LaCasse, P. Colletti, Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder. Arch. Gen. Psychiatry57(2000), 119–27.
74. M. Dolan, W. J. Deakin, N. Roberts, I. Anderson, Serotonergic and cognitive impairment in impulsive aggressive personality disordered offenders: are there implications for treatment? Psychol. Med.32(2002), 105–17.
75. R. DeRijk, M. Schaaf, E. de Kloet, Glucocorticoid receptor variants: clinical implications. J. Steroid. Biochem. Mol. Biol.81(2002), 103–22.
76. C. L. Raison, A. H. Miller, Whennot enoughis toomuch: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am. J. Psychiatry160(2003), 1554–65.